Avantor, Inc. (AVTR)

NYQ – Real Time Price. Currency in USD

8.17

+0.20 (2.51%)

At close: May 12, 2026, 4:00 PM EDT

8.18

+0.01 (0.12%)

After-hours: May 12, 2026, 7:38 PM EDT

07.05.2026

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

We do not believe Humana's current share price reflects the company's earnings power, and as industry conditions normalize, we believe it can return to target margins over the long term. We initiated a position in Antero Resources, a natural gas exploration and production company, to gain exposure given our constructive long-term outlook for US natural gas. We exited our position in First Advantage, a leader in the background check space, to pursue other opportunities with less macro exposure and AI-disruption concerns.

30.04.2026

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline

AVTR benefits from stable Q1 revenues and improving demand trends, though margin pressure and volume softness weigh on profitability.

30.04.2026

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Avantor, Inc. reported a slight beat on 1Q26 EPS and revenue, but underlying organic growth and margins remain under pressure. Negative organic growth, margin compression, and subdued cash flow signal only early stabilization, not a confirmed recovery, especially in the VWR segment. Management reaffirmed 2026 guidance and expects sequential improvement, but the recovery is execution-dependent and gradual, with margins likely to remain below historical peaks.

29.04.2026

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

29.04.2026

Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates

Avantor, Inc. (AVTR) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.23 per share a year ago.

29.04.2026

Avantor® Reports First Quarter 2026 Results

Net sales of $1,581 million Net income of $43 million; Adjusted EBITDA of $219 million Diluted GAAP EPS of $0.06; adjusted EPS of $0.17 Operating cash flow of $59 million; free cash flow of $25 million Reaffirms FY 2026 guidance RADNOR, Pa., April 29, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2026.

23.04.2026

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

RADNOR, Pa., April 23, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Ludovic Brellier will join the company as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer on May 1, 2026.

Videos

No Data

There is no data to display

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
AVTR	Raymond James	Market Perform	undefined >> undefined	November 4th 2025
AVTR	Barclays	Equal Weight	undefined >> $12	October 30th 2025
AVTR	JP Morgan	Neutral	undefined >> $12	October 30th 2025
AVTR	Jefferies	Hold	undefined >> undefined	August 1st 2025
AVTR	Goldman	Neutral	undefined >> $14	April 29th 2025
AVTR	TD Cowen	Hold	undefined >> $16	April 28th 2025
AVTR	Stifel	Hold	undefined >> $14	April 28th 2025
AVTR	Morgan Stanley	Equal Weight	undefined >> undefined	April 28th 2025

Press releases

29.04.2026

Avantor® Reports First Quarter 2026 Results

23.04.2026

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

22.04.2026

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Avantor, Inc. (NYSE: AVTR) breached their fiduciary duties to shareholders.

21.04.2026

Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing

Portfolio now includes standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems for R&D through high-volume manufacturing Company to attend INTERPHEX 2026 in New York City from April 21-23 RADNOR, Pa., April 21, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to the life sciences and advanced technology industries, today announced the expansion of its Masterflex brand across its fluid handling portfolio, bringing together standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems.

Avantor, Inc. (AVTR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Avantor, Inc. (AVTR)

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Videos

No Data

Upgrades / Downgrades

Press releases

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Videos

No Data

Upgrades / Downgrades

Press releases

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing

Search stocks

Avantor, Inc. (AVTR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Avantor, Inc. (AVTR)

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Videos

No Data

Upgrades / Downgrades

Press releases

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Videos

No Data

Upgrades / Downgrades

Press releases

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing